Pharma-Bio Serv, Inc.
PBSV
$0.59
$0.024.07%
OTC PK
| 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -100.62% | 33.93% | 144.62% | 103.14% | 134.18% |
| Total Depreciation and Amortization | 27.31% | 31.31% | 36.02% | 11.40% | 3.56% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 295.34% | -28.25% | 522.52% | 24.07% | 127.30% |
| Change in Net Operating Assets | 398.25% | 231.74% | 3.04% | -132.35% | -105.04% |
| Cash from Operations | 256.76% | 135.28% | 56.96% | -159.17% | -74.58% |
| Capital Expenditure | 99.75% | -5.26% | -- | -- | -9,912.50% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -360.67% | -55.83% | -602.24% | 120.75% | -95.52% |
| Cash from Investing | -599.53% | -55.86% | -603.16% | 120.75% | -97.66% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -194.12% | -647.83% | -- | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | 0.13% | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -194.12% | -0.73% | -- | 100.00% |
| Foreign Exchange rate Adjustments | 375.00% | 161.97% | 358.79% | -257.85% | 95.19% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -334.02% | -38.07% | -79.54% | 113.39% | -96.74% |